Psychedelics do not simply numb symptoms—they dismantle the rigid modularity of the Default Mode Network (DMN) and reopen a critical window of neuroplasticity (Nature, 2023). We provide physician-guided integration therapy to turn transient neural plasticity into permanent behavioral recovery.
Research led by the Gul Dölen Lab (Nature, 2023) and David Olson Lab (Cell Reports, 2018) confirms that classical psychedelics temporarily reopen a juvenile-like critical period of neuroplasticity.
Within 24 hours of 5-HT2A stimulation, prefrontal pyramidal neurons display a marked increase in dendritic spine density and neurite branching, mediated by intracellular TrkB receptors.
The Default Mode Network (responsible for depressive rumination and self-critical loops) temporarily quiets. This zero-point state (Shoonya) allows entrenched cognitive habits to be overwritten.
A molecule opens the window, but integration directs what is built. Without structured clinical therapy in the 14 days following, newly formed synaptic connections atrophy back into old default patterns.
Allopathic taxonomy and physician-led harm reduction protocols grounded in receptor kinetics.
Psilocybin & Psilocin. 5-HT2A agonist promoting rapid dendritic spinogenesis and BDNF upregulation (Ly et al., Cell Reports 2018).
Lysergic Acid Diethylamide (LSD). High-affinity poly-pharmacological binding with prolonged receptor residence time.
Mescaline, 2C-B, MDMA. Substituted catecholamine core promoting oxytocin release and fear-extinction learning in the amygdala.
Evidence-based exclusion criteria: personal or familial pedigree of Bipolar I, Schizophrenia, or concurrent SSRI/MAOI pharmacotherapy.
4-PO-DMT (Psilocybin) • 4-HO-DMT (Psilocin)
Induces profound Default Mode Network down-regulation, opening a documented 7–14 day critical window of neuroplasticity for behavioral re-learning.
Screen against lithium and tramadol. Require blood pressure and heart rate monitoring for transient autonomic activation.
Nardou, R., Sawyer, E., Song, Y.J. et al. (Gul Dölen Lab)
Petri, G., Expert, P., Turkheimer, F. & Carhart-Harris, R.
Ly, C., Greb, A.C., Cameron, L.P. et al. (David Olson Lab)
Daws, R.E., Timmermann, C., Giribaldi, B. et al.

As licensed physicians trained in Augmented Psychotherapy at the MIND Foundation in Berlin, our clinical team bridges pharmacological safety with somatic integration. We do not sell substances or promote unverified panaceas—we guide patients before and during their critical window of recovery.
Integrates neuroplasticity frameworks with CBT and ACT, mapping the post-journey critical window into durable behavioral change.
Clinical hypnotherapy and medical safety audits for 3-phase international retreat participants.
Somatic nervous system regulation, autonomic down-regulation, and trauma integration in legal European jurisdictions.

Providing safe, unpolluted peer containers in New Delhi where individuals can deconstruct altered-state experiences through expressive art, somatic anchoring, and physician-guided harm reduction.
Inquire regarding 1-on-1 Clinical Integration Therapy, retreat preparation, or request an invitation to the next vetted Sunday Community Circle.